Clinical Trials
102
Active:1
Completed:59
Trial Phases
5 Phases
Phase 1:10
Phase 2:12
Phase 3:4
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (84 trials with phase data)• Click on a phase to view related trials
Not Applicable
42 (50.0%)Phase 4
16 (19.0%)Phase 2
12 (14.3%)Phase 1
10 (11.9%)Phase 3
4 (4.8%)Inhaled Sedation in Critically Ill Patients
Phase 4
Not yet recruiting
- Conditions
- SedationAirway Extubation
- Interventions
- First Posted Date
- 2025-06-03
- Last Posted Date
- 2025-06-05
- Target Recruit Count
- 620
- Registration Number
- NCT07000526
- Locations
- 🇪🇸
Hospital Vega Baja, Orihuela, Alicante, Spain
🇪🇸Hospital Universitario Doctor José Molina Orosa, Arrecife, Lanzarote-Canary Islands, Spain
🇪🇸Hospital Universitario de Albacete, Albacete, Spain
Dose-finding for Dobutamine During Transitional Circulation in Very Preterm Infants
Phase 1
Recruiting
- Conditions
- Infant, Premature, DiseasesCirculatory and Respiratory Physiological Phenomena
- Interventions
- Drug: Intravenous dobutamine 5 mcg/kg/minDrug: Intravenous dobutamine 7.5 mcg/kg/minDrug: Intravenous dobutamine 10 mcg/kg/minDrug: Intravenous dobutamine 12.5 mcg/kg/minDrug: Intravenous dobutamine 15 mcg/kg/min
- First Posted Date
- 2025-03-17
- Last Posted Date
- 2025-03-17
- Target Recruit Count
- 30
- Registration Number
- NCT06878742
- Locations
- 🇪🇸
Hospital Universitario Quironsalud, Madrid, Spain
🇪🇸Hospital Universitario 12 de Octubre, Madrid, Spain
🇪🇸Hospital Universitario La Paz, Madrid, Spain
Phase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults
Phase 1
Not yet recruiting
- Conditions
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Interventions
- Biological: Autologous CD19/CD22 CAR T cellsBiological: Allogeneic CART-NKG2D cells
- First Posted Date
- 2024-11-28
- Last Posted Date
- 2024-11-28
- Target Recruit Count
- 10
- Registration Number
- NCT06709469
- Locations
- 🇪🇸
Hospital Universitario La Paz, Madrid, Spain
Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus
Phase 4
Not yet recruiting
- Conditions
- Kidney Disease, ChronicTransplant Recipient (Kidney)Immunosuppression
- Interventions
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2024-12-03
- Target Recruit Count
- 160
- Registration Number
- NCT06701825
- Locations
- 🇪🇸
Hospital La Paz, Madrid, Comunidad De Madrid, Spain
A Multicentre, Randomised, Single-blind, Controlled Protocol to Evaluate the Efficacy of Early Administration of Botulinum Toxin for Primary Midline Closure in Patients With Open Abdomen.
Phase 4
Not yet recruiting
- Conditions
- Botulinum Toxin Type AClinical TrialAbdominal WallOpen Abdomen
- Interventions
- Other: CONTROL
- First Posted Date
- 2024-08-15
- Last Posted Date
- 2024-08-15
- Target Recruit Count
- 50
- Registration Number
- NCT06556030
- Prev
- 1
- 2
- 3
- 4
- 5
- 21
- Next
News
No news found